Health

Manulife launches first-in-market, fully digitized cashless service for day surgeries

HONG KONG, Nov. 26, 2019 /PRNewswire/ -- Manulife Hong Kong today launched Cashless Day Surgery eService, the market's first all-digital cashless service which enables customers to obtain speedy claims pre-approval for colonoscopy and gastroscopy (OGD) day surgery simply by entering their Hong Ko...

2019-11-26 18:31 3698

Ping An Good Doctor Awarded "Listed Enterprise of the Year 2019" by Bloomberg Businessweek/Chinese Edition

SHANGHAI, Nov. 26, 2019 /PRNewswire/ -- Bloomberg Businessweek/Chinese Edition, a renowned Asian financial magazine, announced the winners of the "Listed Enterprises of the Year 2019". The world's leading online healthcare ecosystem platform,Ping An Healthcare and Technology Company Limited ("Pin...

2019-11-26 18:04 4908

Novoheart to Co-develop First of its Kind Human Heart-in-a-Jar Model of Heart Failure with AstraZeneca

* Heart failure is a global pandemic with an estimated 64.3 million cases worldwide in 2017, costing overUS$100B per year * Drug developers currently lack effective humanized models for preclinical testing of targeted drug candidates in heart failure with preserved ejection fraction * The c...

2019-11-26 16:31 2476

Program of Building of High-Quality and Efficient Health Service System and Empirical Study in the Context of Aging Kicked off in Beijing

BEIJING, Nov. 25, 2019 /PRNewswire/ -- The MOU signing ceremony and launch seminar forProgram of Building of High-Quality and Efficient Health Service System and Empirical Study in the Context of Aging took place in Beijing today. Government officials and Amgen executives who were present include...

2019-11-25 22:53 1913

Blockchain in Healthcare Will Live Up to the Hype Versus Reality for Stakeholders

SANTA CLARA, California, Nov. 25, 2019 /PRNewswire/ -- With the healthcare industry increasingly going digital, blockchain technology provides the much-needed trust, security, and auditability for healthcare data on its intelligence journey, which allows blockchain to complement healthcare artifi...

2019-11-25 22:10 1559

Venturing into the future of healthcare with AI - SonoScape at Medica 2019

DUSSELDORF, Germany, Nov. 25, 2019 /PRNewswire/ -- SonoScape, as one of the leading providers of medical ultrasound and endoscopy solutions, presented its latest products and technologies in the world's largest medical event Medica: its first echoendoscope EG-UR5 (endoscopic ultrasound), a new 4-...

2019-11-25 20:28 1691

Xinhua Silk Road: Er-Kang highly recognized for "going global" achievements in Cambodia

PHNOM PENH, Cambodia, Nov. 25, 2019 /PRNewswire/ -- Hunan Er-Kang (Cambodia) Investment Co., Ltd., an overseas arm ofChina's Hunan Er-Kang Pharmaceutical Co., Ltd. (300267.SZ), has recently received a delegation of Communist Party led by Du Jiahao, Secretary of the CPC Hunan Provincial Committee,...

2019-11-25 18:16 1655

USD 10 million transaction generated at Asia Agri-Tech Expo & Forum 2019 concluded on 2 November

TAIPEI, Nov. 25, 2019 /PRNewswire/ -- Taiwan premier agricultural international exhibition, Asia Agri-Tech Expo & Forum 2019, has concluded in November at Taipei Nangang Exhibition Center, Hall 1. Co-located with Aquaculture Taiwan and Livestock Taiwan, the triple show attracted more than 25,000 ...

2019-11-25 15:58 3787

ActLight: Ultra Small, Very Low Power Consumption Heart Rate Monitoring Sensor for Hearables? You Need the ActLight Dynamic Photodiode

LAUSANNE, Switzerland, Nov. 25, 2019 /PRNewswire/ -- Long battery life, precision of measurements and very small size are the key requirements for vital signs monitoring sensors in hearable devices. The Dynamic PhotoDiod...

2019-11-25 08:19 2183

Pfizer Unveils Positive Results from Asian Subgroup Analysis of ARCHER 1050

SINGAPORE, Nov. 25, 2019 /PRNewswire/ -- Pfizer Inc. (NYSE: PFE) today announced the efficacy and tolerability results from the subgroup analysis of Asian patients enrolled in the ARCHER 1050, a randomized, multicenter, multinational, open-label Phase 3 study evaluating the efficacy of VIZIMPRO® ...

2019-11-25 08:15 2175

Positive Interim Efficacy Data from GDC-0084 Phase II Study in Glioblastoma Released at SNO Conference

SYDNEY, Nov. 25, 2019 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to share with investors interim data from its ongoing phase II study of GDC-0084 in glioblastoma, the most common and most aggressive form of...

2019-11-25 07:00 2127

CPC Indonesia Design Week Concludes with Local Endorsement

MAKASSAR, Indonesia, Nov. 23, 2019 /PRNewswire/ -- The International Water, Sanitation and Hygiene Foundation's (IWSH) Community Plumbing Challenge (CPC) program has completed its latest installment, a Design Week project in the coastal village of Kampung Nelayan Untia. An intensive four-day ass...

2019-11-23 04:01 1978

WuXi Vaccines to Build a $240 Million Manufacturing Facility in Ireland

DUNDALK, Ireland, Nov. 23, 2019 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development, and manufacturing, announced that its subsidiary WuXi Vaccines, engaged in ...

2019-11-23 01:55 5547

Patient Enrollment Completed in Phase III Clinical Study of Adapalene-Clindamycin Combination Gel in China

BEIJING, Nov. 22, 2019 /PRNewswire/ -- China Ophthalmology Focus Limited ("COPFL") today announced that its wholly-owned subsidiary, Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Limited ("ZKO") has successfully completed patient enrollment of the Phase III study of Adapalene-Clindamycin Combin...

2019-11-22 23:50 3475

Guardant Health AMEA wins this year's Growth Excellence Leadership Award by Frost & Sullivan

SINGAPORE, Nov. 22, 2019 /PRNewswire/ -- Guardant Health AMEA has won Frost & Sullivan's Growth Excellence Leadership Award under the Best Practices Category for 2019 Asia-Pacific Liquid Biopsy for Precision Oncology. "We are delighted to receive this prestigious award from Frost & Sullivan. T...

2019-11-22 15:37 1682

Analytical Wizards secures Series A funding from Sopris Capital

EDISON, New Jersey, Nov. 21, 2019 /PRNewswire/ -- Analytical Wizards, a New Jersey-based global healthcare analytics firm, has announced that it has secured Series A funding from Sopris Capital. Founded in 2015 Analytical Wizards leverages the power of AI/ML, technology, and domain expertis...

2019-11-22 02:11 2262

Thrombosis Research Institute (TRI) Launches Innovative Risk Calculator for Predicting Stroke, Major Bleeding and Mortality in Atrial Fibrillation Over Two Years

- Rapidly predicts differences in risk when treated with different anticoagulants or not treated  - Crucially, risk is calculated using patient-specific measurements rather than standardised measures, providing personalised results  - Underscored by data of 52,000 AF patients and externally vali...

2019-11-21 23:05 2795

Initiation of a Phase 2 Multicenter Study of 18F-APN-1607, a Novel Diagnostic PET Imaging Tracer for the Characterization of Tau Burden in Alzheimer's Disease

TAIPEI, Nov. 21, 2019 /PRNewswire/ -- APRINOIA Therapeutics, Inc. announced today that it has initiated a Phase 2 multicenter, multinational study of18F -APN-1607 in the US for its lead tau positron emission tomography (PET) tracer in Alzheimer's Disease (AD). The study (NCT number: NCT04141150) w...

2019-11-21 23:00 1547

Seed Health Announces Research Partnership with Atmo Biosciences to Evaluate Impact of Probiotics With First Ingestible Gas Sensor Technology

First tech-enabled clinical trial will use new biomarkers to measure effect of Seed's Daily Synbiotic on gut microbiome after antibiotic use LOS ANGELES, Nov. 21, 2019 /PRNewswire/ -- Seed Health, a microbial sciences company, today announced a research partnership with digital health company, At...

2019-11-21 21:00 1304

Global Cord Blood Corporation to Report Second Quarter and First Half Fiscal 2020 Financial Results

HONG KONG, Nov. 21, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that it plans to release unaudited financia...

2019-11-21 20:00 5944